The ErbB receptors are implicated in the development and progression of various cancers, including breast, lung, and colorectal cancers. Overexpression or mutation of these receptors can lead to uncontrolled cell proliferation and survival, contributing to oncogenesis. For instance, the amplification of the HER2 gene is observed in approximately 20-30% of breast cancers and is associated with an aggressive tumor phenotype.
